Women Engaging in Quitting Smoking Together
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/30/2019 |
| Start Date: | May 2015 |
| End Date: | December 2018 |
Distress Tolerance Treatment for Weight Concern in Smoking Cessation Among Women
The long-term goal of this program of research is to develop and disseminate an efficacious,
group-based distress tolerance treatment for weight concern (DT-W) that will significantly
increase smoking cessation rates among women. The objective of this project is to conduct a
preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education
(HE) comparison intervention, in which both groups also receive standard behavioral smoking
cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and
examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking
outcomes at 1-, 3-, and 6-month follow-ups.
group-based distress tolerance treatment for weight concern (DT-W) that will significantly
increase smoking cessation rates among women. The objective of this project is to conduct a
preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education
(HE) comparison intervention, in which both groups also receive standard behavioral smoking
cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and
examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking
outcomes at 1-, 3-, and 6-month follow-ups.
Inclusion Criteria:
female
- at least 18 years of age
- smoke 5 or more cigarettes per day
- daily smoker for at least the past year
- report motivation to quit smoking in the next month of at least 5 on a 10 point scale
- report concern of at least 50 on at least one of two 100 point scales assessing weight
concern
- able to travel to study location for study appointments
Exclusion Criteria:
- current use of other smoking cessation or weight loss therapies
- current use of other tobacco products at least weekly
- diagnosis or treatment for non-nicotine substance use disorder with substance use
during the past 6 months
- lifetime diagnosis or treatment of eating disorder, bipolar disorder, schizophrenia,
or schizoaffective disorder
- score above established cut-offs on self-report screening measures of depressive
symptomology, eating disorder symptomology, alcohol use disorder, or drug use disorder
- current suicidality or homicidality
- medical condition that is a contraindication for the use of transdermal nicotine patch
- lives at same address as current or past participant
We found this trial at
1
site
593 Eddy Street
Providence, Rhode Island 02903
Providence, Rhode Island 02903
401-444-4000
Principal Investigator: Erika L Bloom, PhD
Phone: 401-450-2731
Rhode Island Hospital Founded in 1863, Rhode Island Hospital in Providence, RI, is a private,...
Click here to add this to my saved trials
